Skip Navigation U.S. Department of Health and Human Services
Agency for Healthcare Research Quality
Archive print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

Figure 10:  Organization of Thalidomide Efficacy Tables


Newly diagnosed/previously untreated multiple myeloma

Advanced/refractory/resistant multiple myeloma

Thalidomide only

Table 2

Table 3

Thalidomide plus dexamethasone

Table 4

Table 5

Thalidomide plus other agents

Table 6

Table 7

Thalidomide pre- or post-SCT

Table 8

Return to Document

The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care